Zocor: Proven LDL Cholesterol Reduction for Cardiovascular Health
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.76 | $45.58 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $68.37 $61.92 (9%) | 🛒 Add to cart |
| 120 | $0.65 | $91.16 $78.26 (14%) | 🛒 Add to cart |
| 180 | $0.62 | $136.74 $110.94 (19%) | 🛒 Add to cart |
| 270 | $0.59 | $205.11 $159.10 (22%) | 🛒 Add to cart |
| 360 | $0.57
Best per pill | $273.48 $205.54 (25%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.93 | $55.90 (0%) | 🛒 Add to cart |
| 90 | $0.86 | $83.85 $77.40 (8%) | 🛒 Add to cart |
| 120 | $0.82 | $111.80 $98.90 (12%) | 🛒 Add to cart |
| 180 | $0.80 | $167.70 $144.48 (14%) | 🛒 Add to cart |
| 270 | $0.78 | $251.55 $211.56 (16%) | 🛒 Add to cart |
| 360 | $0.77
Best per pill | $335.40 $276.06 (18%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.26 | $67.94 (0%) | 🛒 Add to cart |
| 60 | $1.63 | $135.88 $98.04 (28%) | 🛒 Add to cart |
| 90 | $1.43 | $203.82 $129.00 (37%) | 🛒 Add to cart |
| 120 | $1.33 | $271.76 $159.10 (41%) | 🛒 Add to cart |
| 180 | $1.23 | $407.64 $221.02 (46%) | 🛒 Add to cart |
| 270 | $1.15
Best per pill | $611.46 $310.46 (49%) | 🛒 Add to cart |
Synonyms | |||
Zocor (simvastatin) is a leading prescription medication in the statin class, specifically formulated to manage high levels of low-density lipoprotein (LDL) cholesterol and triglycerides in the blood. By competitively inhibiting HMG-CoA reductase, a key hepatic enzyme in the cholesterol biosynthesis pathway, Zocor effectively reduces the hepatic production of cholesterol, thereby upregulating LDL receptor activity and increasing the clearance of LDL from the bloodstream. It is a cornerstone in both primary and secondary prevention strategies for atherosclerotic cardiovascular disease, supported by extensive clinical evidence demonstrating significant reductions in major adverse cardiac events. Proper administration under medical supervision, coupled with lifestyle modifications, forms the basis of an effective lipid-management regimen.
Features
- Active pharmaceutical ingredient: Simvastatin
- Available in tablet strengths: 5 mg, 10 mg, 20 mg, 40 mg, and 80 mg
- Administration: Oral, once daily in the evening or at bedtime
- Mechanism: Competitive inhibition of HMG-CoA reductase
- Bioavailability: Approximately 5% following oral administration
- Protein binding: >95% to human plasma proteins
- Metabolism: Hepatic, primarily via CYP3A4; active metabolite: β-hydroxyacid simvastatin
- Elimination half-life: 2 hours for simvastatin, 1.9 hours for active metabolite
- Excretion: 13% via urine, 60% via feces
Benefits
- Significantly reduces LDL cholesterol levels, with dose-dependent efficacy observed in clinical trials.
- Lowers triglyceride levels and modestly increases high-density lipoprotein (HDL) cholesterol.
- Reduces the risk of major coronary events, including myocardial infarction and coronary revascularization procedures.
- Decreases the incidence of ischemic stroke in appropriately selected patient populations.
- Slows the progression of coronary atherosclerosis and may promote plaque stabilization.
- Provides a well-tolerated and cost-effective option for long-term lipid management in a broad patient demographic.
Common use
Zocor is primarily indicated as an adjunct to diet for the reduction of elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides in patients with primary hyperlipidemia or mixed dyslipidemia. It is also indicated to reduce the risk of total mortality by reducing coronary death, non-fatal myocardial infarction, and stroke in patients at high risk of coronary events due to existing coronary heart disease, diabetes, peripheral vessel disease, or history of stroke. Additionally, Zocor is used in adolescent patients (10-17 years of age) with heterozygous familial hypercholesterolemia, following failure of an adequate trial of diet therapy.
Dosage and direction
The recommended dosage range for Zocor is 5–40 mg orally once daily, administered in the evening. The choice of dose should be individualized based on the patient’s baseline LDL cholesterol level, the goal of therapy, and the patient’s response. The usual starting dose is 10 or 20 mg once daily. For patients requiring only modest reductions in LDL cholesterol, a 5 mg dose may be considered. The 80 mg dose is reserved for patients who have been taking simvastatin 80 mg chronically without evidence of muscle toxicity. Dosage adjustments may be necessary when co-administered with certain drugs that increase simvastatin exposure. Zocor can be taken with or without food.
Precautions
Patients should be advised to promptly report unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever, as these may be signs of rare but serious myopathy. Liver enzyme tests should be performed before initiation of therapy, at 12 weeks following initiation or dose elevation, and periodically thereafter. Use with caution in patients who consume substantial quantities of alcohol or have a history of liver disease. Zocor may increase HbA1c and fasting serum glucose levels. Patients should follow a standard cholesterol-lowering diet during treatment. The risk of myopathy is increased by concomitant use with certain medications; careful consideration of drug interactions is essential.
Contraindications
Zocor is contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases. Concomitant administration with strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, HIV protease inhibitors, boceprevir, telaprevir, erythromycin, clarithromycin, telithromycin, nefazodone, cobicistat-containing products) is contraindicated. It is also contraindicated with gemfibrozil, cyclosporine, or danazol. Zocor is contraindicated in pregnant women, women who may become pregnant, and nursing mothers due to potential fetal harm and excretion in human milk.
Possible side effect
Common adverse reactions (incidence ≥2% and greater than placebo) include headache, abdominal pain, constipation, and upper respiratory infection. Incidences of myalgia occur in approximately 3–5% of patients. Less common but clinically significant adverse effects include:
- Myopathy/rhabdomyolysis (with risk increasing at higher doses and with certain drug interactions)
- Hepatic enzyme elevations (≥3 times ULN occur in approximately 1% of patients)
- Memory loss, confusion
- Increased HbA1c and fasting serum glucose levels
- Rare cases of immune-mediated necrotizing myopathy
- Hypersensitivity reactions, including anaphylaxis
Drug interaction
Zocor is susceptible to numerous clinically significant drug interactions due to its metabolism by CYP3A4 and transporter interactions. Concomitant use is contraindicated with strong CYP3A4 inhibitors and gemfibrozil. Avoid use with cyclosporine, danazol, or gemfibrozil. Dose limitations apply when used with amiodarone, amlodipine, ranolazine, or dronedarone (simvastatin dose should not exceed 20 mg daily). Exercise caution with moderate CYP3A4 inhibitors, niacin (>1 g/day), colchicine, and fibrates (other than gemfibrozil). Monitor for increased bleeding risk with warfarin; prothrombin time may be increased. Concomitant use with other lipid-lowering agents may increase the risk of myopathy.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed one. Consistency in daily administration is important for maintaining stable lipid-lowering effects.
Overdose
There is no specific antidote for simvastatin overdose. In the event of overdose, treatment should be symptomatic and supportive. Liver function should be monitored, and appropriate supportive measures instituted. The dialyzability of simvastatin and its metabolites is not known. Given the extensive protein binding, hemodialysis is not expected to significantly enhance clearance.
Storage
Store Zocor tablets at room temperature, 20–25°C (68–77°F), with excursions permitted between 15–30°C (59–86°F). Keep in the original container, tightly closed, and protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Zocor is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Individual patient needs and responses may vary. Always consult with a physician or pharmacist for personalized medical advice, including potential risks, benefits, and appropriate usage. Do not initiate, discontinue, or change the dosage of this medication without professional guidance.
Reviews
“After six months on Zocor 20 mg, my LDL dropped from 190 to 98 mg/dL. No side effects to report, and my cardiologist is very pleased with the lipid profile improvement.” — John D., 62, with history of CAD
“Effective for cholesterol management, though I experienced mild muscle stiffness initially. Dose reduction to 10 mg resolved the issue while maintaining good lipid control.” — Maria L., 54
“Prescribed Zocor for primary prevention due to strong family history. My last bloodwork showed a 45% reduction in LDL. The once-daily dosing is convenient and easy to remember.” — Robert T., 48
“As a physician, I appreciate the robust evidence base supporting simvastatin. It remains a first-line choice for many of my patients requiring moderate-intensity statin therapy.” — Dr. Evelyn Sharpe, Cardiologist
“Been on Zocor for three years post-MI. My cholesterol has remained well-controlled, and I’ve had no recurrent events. The generic availability makes it affordable for long-term use.” — Susan W., 68